4,900
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Fiber biodurability and biopersistence: historical toxicological perspective of synthetic vitreous fibers (SVFs), the long fiber paradigm, and implications for advanced materials

&
Pages 811-866 | Received 10 Jul 2022, Accepted 23 Nov 2022, Published online: 07 Mar 2023

References

  • Adachi S, Kawamura K, Kimura K, Takemoto K. 1991. Tumorigenicity of fine man-made fibers after intratracheal administrations to hamsters. Env Res. 54(1):52–73.
  • Adachi S, Kawamura K, Kimura K, Takemoto K. 1992. Tumor incidence was not related to the thickness of visceral pleural in female Syrian hamsters intratracheally administered amphibole asbestos or manmade fibers. Environ Res. 58(1):55–65.
  • Arts JHE, Hadi M, Irfan M-A, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, et al. 2015. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul Toxicol Pharmacol. 71(2 Suppl): s1–s27.
  • Assuncao J, Corn M. 1975. The effects of milling on diameters and lengths of fibrous glass and chrysotile asbestos fibers. Am Ind Hyg Assoc J. 36(11):811–819.
  • ATSDR. 2002. Expert panel on the health effects of asbestos and synthetic vitreous fibers (SVF): the influence of fiber length. Premeeting Comments; New York, NY, October 29–30, 2002. Atlanta, GA: U.S. Dept. of Health and Human Services-Public Health Service-Agency for Toxic Substances and Disease Registry (ATSDR).
  • Bellmann B, Muhle H, Creutzenberg O, Ernst H, Brown RC, Sebastien P. 2001. Effects of nonfibrous particles on ceramic fiber (RCF1) toxicity in rats. Inhal Toxicol. 13(10):877–901.
  • Bellmann B, Muhle H, Creutzenberg O, Ernst H, Muller M, Bernstein DM, Riego Sintes JM. 2003. Calibration study on subchronic inhalation toxicity of man-made vitreous fibers in rats. Inhal Toxicol. 15(12):1147–1177.
  • Bellmann B, Muhle H, Kamstrup O, Draeger UF. 1994. Investigation on the durability of man-made vitreous fibers in rat lungs. Environ Health Perspect. 102 Suppl 5(Suppl 5):185–189.
  • Bellmann B, Muhle H, Kamstrup O, Draeger UF. 1995. Investigation on the biodurability of chemically different stone wool fibres. Exp Toxicol Pathol. 47(2–3):195–201.
  • Bellmann B, Schaeffer HA, Muhle H. 2010. Impact of variations in the chemical composition of vitreous mineral fibers on biopersistence in rat lungs and consequences for regulation. Inhal Toxicol. 22(10):817–827.
  • Bernstein DM. 2007. Synthetic vitreous fibers: a review toxicology, epidemiology and regulations. Crit Rev Toxicol. 37(10):839–886.
  • Bernstein DM. 2022. The health effects of short fiber chrysotile and amphibole asbestos. Crit Rev Toxicol. 52(2):89–112.
  • Bernstein DM, Chevalier J, Smith P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol. 17(9):427–449.
  • Bernstein DM, Drew RT, Kuschner M. 1980. Experimental approaches for exposure to sized glass fibers. Environ Health Perspect. 34:47–57.
  • Bernstein DM, Morscheidt C, Grimm HG, Thévenaz P, Teichert U. 1996. Evaluation of soluble fibers using the inhalation biopersistence model, a nine-fiber comparison. Inhalation Toxicol. 8(4):345–385.
  • Bernstein DM, Riego Sintes JM. 1999. Methods for the determination of the hazardous properties for the human health of manmade mineral fibres (MMMF). Document No.: EUR18748EN. Ispra, Italy: European Commission Joint Research Centre-Institute for Health and Consumer Protection-Toxicology and Chemical Substances. https://publications.jrc.ec.europa.eu/repository/handle/JRC18422
  • Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. 2001a. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal Toxicol. 13(10):823–849.
  • Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. 2001b. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumor response in rats. Inhal Toxicol. 13(10):851–875.
  • Bernstein DM, Thevenaz P, Fleissner H, Anderson R, Hesterberg TW, Mast R. 1995. Evaluation of the oncogenic potential of man-made vitreous fibres: the inhalation model. Ann Occup Hyg. 39(5):661–672.
  • Bermudez E, Mangum J, Moss O, Wong B, Everitt J. 2003. Pleural dosimetry and pathobiological responses in rats and hamsters exposed subchronically to MMVF 10a fiberglass. Toxicol Sci. 74(1):165–173.
  • Berry G. 1999. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhal Toxicol. 11(2):111–130.
  • Biswas R, Hamilton RF, Jr., Holian A. 2014. Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO. J Immunol Res. 2014:304180.
  • Brown JS, Gordon T, Price O, Asgharian B. 2013. Thoracic and respiratory particle definitions for human health risk assessment. Part Fibre Toxicol. 10(12):12–12.
  • Brown RC, Bellmann B, Muhle H, Davis JM, Maxim LD. 2005. Survey of the biological effects of refractory ceramic fibres: overload and its possible consequences. Ann Occup Hyg. 49(4):295–307.
  • Brown RC, Sebastien P, Bellmann B, Muhle H. 2000. Particle contamination in experimental fiber preparations. Inhal Toxicol. 12(Suppl 3):99–107.
  • Campopiano A, Cannizzaro A, Angelosanto F, Astolfi ML, Ramires D, Olori A, Canepari S, Iavicoli S. 2014. Dissolution of glass wool, rock wool and alkaline earth silicate wool: morphological and chemical changes in fibers. Regul Toxicol Pharmacol. 70(1):393–406.
  • Carthew P, Edwards RE, Dorman BM, Brown RC, Young J, Laskowski JJ, Wagner JC. 1995. Intrapleural administration of vitreous high duty ceramic fibres and heated devitrified ceramic fibres does not give rise to pleural mesothelioma in rats. Hum Exp Toxicol. 14(8):657–661.
  • Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA. 105(26):9035–9040.
  • Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, Bradley M, Megson IL, Donaldson K. 2011. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 8(1):27.
  • Cho WS, Duffin R, Poland CA, Duschl A, Oostingh GJ, Macnee W, Bradley M, Megson IL, Donaldson K. 2012. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology. 6(1):22–35.
  • Collier CG, Morris KJ, Launder KA, Humphreys JA, Morgan A, Eastes W, Townsend S. 1994. The behavior of glass fibers in the rat following intraperitoneal injection. Regul Toxicol Pharmacol. 20(3 Pt 2): s89–103.
  • Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. 1983. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis. 128(2 Pt 2): s42–46.
  • Cullen RT, Searl A, Buchanan D, Davis JM, Miller BG, Jones AD. 2000. Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestos. Inhal Toxicol. 12(10):959–977.
  • Davis JMG. 1976. Pathological aspects of the injection of glass fiber into the pleural and peritoneal cavities of rats and mice. In: Occupational exposure to fibrous glass: Proceedings of a Symposium, June 26-27, 1974. College Park, MD: U.S. Dept. of Health, Education, and Welfare–Center for Disease Control–National Institute for Occupational Safety and Health (NIOSH)–Division of Criteria Documentation and Standards Development. p. 141–150.
  • Davis JM, Beckett ST, Bolton RE, Collings P, Middleton AP. 1978. Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer. 37(5):673–688.
  • Davis JM, Dungworth DL, Boorman GA. 1996. Concordance in diagnosis of mesotheliomas. Toxicol Pathol. 24(5):662–663.
  • Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA. 2011. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine. 6(1):143–156.
  • Donaldson K, Murphy FA, Duffin R, Poland CA. 2010. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 7(1):5.
  • Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, Poland C. 2013. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res. 46(3):723–732.
  • Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320(5876):674–677.
  • Dufresne A, Perrault G, Yamato H, Masse S, Begin R. 1999. Clearance of man made mineral fibres from the lungs of sheep. Occup Environ Med. 56(10):684–690.
  • Eastes W, Hadley J. 1996. A mathematical model of fiber carcinogenicity and fibrosis in inhalation and intraperitoneal experiments in rats. Inhal Toxicol. 8(4):323–343.
  • Eastes W, Hadley J, Bender J. 1996. Assessing the biological activity of fibres: insights into the role of fibre durability. J Occup Health Safety Aust NZ. 12(3):381–385.
  • Eastes W, Morris KJ, Morgan A, Launder KA, Collier CG, Davis JA, Mattsom SM, Hadley JG. 1995. Dissolution of glass fibers in the rat lung following intratracheal instillation. Inhal Toxicol. 7(2):197–213.
  • Eastes W, Potter R, Hadley J. 2000. Estimating rock and slag wool fiber dissolution rate from composition. Inhal Toxicol. 12(12):1127–1139.
  • Effros RM, Wesson JA, Mason RJ, Broaddus VC, Murray JF, Nadel JA. 2005. Acid-base balance, Chapter 7. In: Mason RJ, Broaddus VC, Murray JF, Nadel J, editors. Murray and Nadel’s textbook of respiratory medicine. Fourth edition. Philadelphia, PA: Elsevier Inc. p. 171–182.
  • Egnot NS, Benson SM, Vater MF, Hazan R, Patel O, Marsh GM. 2020. Systematic review and meta-analysis of epidemiologic literature evaluating the association between exposure to man-made vitreous fibers and respiratory tract cancers. Regul Toxicol Pharmacol. 112(104585):104512–104585.
  • EIPPCB, Scalet, BM, Garcia Munoz M, Sissa A, Delgado Sancho L, Roudier S, et al. 2013. Best available techniques (BAT) reference document for the manufacture of glass : industrial emissions Directive 2010/75/EU: integrated pollution prevention and control, Publications Office. https://data.europa.eu/doi/10.2791/70161
  • ERG. 2003. Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: the influence of fiber length. March 17, 2003. Atlanta, GA: Agency for Toxic Substances and Disease Registry, Division of Health Assessment and Consultation.
  • Etherington DJ, Pugh D, Silver IA. 1981. Collagen degradation in an experimental inflammatory lesion: studies on the role of the macrophage. Acta Biol Med Ger. 40(10–11):1625–1636.
  • European Commission. 2009. Regulation (EC) No. 1223/2009 of the European Parliament of the Council of 30 November 2009 on cosmetic products (Recast). Official Journal of the European Union, L342/59. Retrieved from: https://health.ec.europa.eu/system/files/2016-11/cosmetic_1223_2009_regulation_en_0.pdf#:∼:text=This%20Regulation%20aims%20at%20simplifying,of%20protection%20of%20human%20health.
  • European Economic Community. 1997. Commission Directive 97/69/EC of 5 December 1997 adapting to technical progress for the 23rd time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities. L343/19. Retrieved from: https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A31997L0069.
  • Everitt JI, Gelzleichter TR, Bermudez E, Mangum JB, Wong BA, Janszen DB, Moss OR. 1997. Comparison of pleural responses of rats and hamsters to subchronic inhalation of refractory ceramic fibers. Environ Health Perspect. 105 Suppl 5(Suppl 5):1209–1213.
  • Flink EB, Dedhia HV, Dinsmore J, Doshi HM, Banks D, Hshieh P. 1992. High-dose magnesium sulfate attenuates pulmonary oxygen toxicity. Crit Care Med. 20(12):1692–1698.
  • Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 10(3):241–247.
  • Ghio AJ, Churg A, Roggli VL. 2004. Ferruginous bodies: implications in the mechanism of fiber and particle toxicity. Toxicol Pathol. 32(6):643–649.
  • Grimm HG, Bernstein DM, Attia M, Richard J, De Reydellet A. 2002. Experience from a long-term carcinogenicity study with intraperitoneal injection of biosoluble synthetic mineral fibers. Inhal Toxicol. 14(8):855–882.
  • Gross P, Kaschak M, Tolker EB, Babyak MA, de Treville RT. 1970. The pulmonary reaction to high concentrations of fibrous glass dust. A preliminary report. Arch Environ Health. 20(6):696–704.
  • Gross P, Tuma J, DeTreville RT. 1971. Lungs of workers exposed to fiber glass. A study of their pathologic changes and their dust content. Arch Environ Health. 23(1):67–76.
  • Guldberg M, de Meringo A, Kamstrup O, Furtak H, Rossiter C. 2000. The development of glass and stone wool compositions with increased biosolubility. Regul Toxicol Pharmacol. 32(2):184–189.
  • Guldberg ML, Madsen A, Sebastien K, Fellman J, Potter R, Bauer J, Searl A, Maquin B, Jubb G. 2003. In-vitro dissolution of vitreous silicate fibres according to EURIMA test guideline – results of two Round Robins. Glass Sci Technol. 76(4):199–205.
  • Gulumian M, Andraos C. 2018. In search of a converging cellular mechanism in nanotoxicology and nanomedicine in the treatment of cancer. Toxicol Pathol. 46(1):4–13.
  • Hamilton RD, Miiller WC, Christensen DR, Anderson R, Hesterberg TW. 1994. Characterization of exposure and dose of manmade vitreous fiber in experimental studies. Environ Health Perspect. 102(Suppl 5):109–112.
  • Harris RL, Jr., Timbrell V. 1975. The influence of fibre shape in lung deposition-mathematical estimates. Inhaled Part. 4(Pt 1):75–89.
  • Hesterberg TW, Axten C, McConnell EE, Oberdörster G, Everitt J, Miiller WC, Chevalier J, Chase GR, Thevenaz P. 1997. Chronic inhalation study of fiber glass and amosite asbestos in hamsters: twelve-month preliminary results. Environ Health Perspect. 105(Suppl 5):1223–1229.
  • Hesterberg TW, Anderson R, Bernstein DM, Bunn WB, Chase GA, Jankousky AL, Marsh GM, McClellan RO. 2012. Product stewardship and science: safe manufacture and use of fiber glass. Regul Toxicol Pharmacol. 62(2):257–277.
  • Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thevenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol. 151(2):262–275.
  • Hesterberg TW, Hart GA. 2000. Lung biopersistence and in vitro dissolution rate predict the pathogenic potential of synthetic vitreous fibers. Inhal Toxicol. 12(Suppl 3):91–97.
  • Hesterberg TW, Hart GA. 2001. Synthetic vitreous fibers: a review of toxicology research and its impact on hazard classification. Crit Rev Toxicol. 31(1):1–53.
  • Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Thevenaz P. 1998. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol. 153(1):68–82.
  • Hesterberg TW, Hart GA, Miiller WC, Chase G, Rogers RA, Mangum JB, Everitt JI. 2002. Use of short-term assays to evaluate the potential toxicity of two new biosoluble glasswool fibers. Inhal Toxicol. 14(3):217–246.
  • Hesterberg TW, Miiller WC, McConnell EE, Chevalier J, Hadley JG, Bernstein DM, Thevenaz P, Anderson R. 1993. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundam Appl Toxicol. 20(4):464–476.
  • Hesterberg TW, Miiller WC, Musselman RP, Kamstrup O, Hamilton RD, Thevenaz P. 1996. Biopersistence of man-made vitreous fibers and crocidolite asbestos in the rat lung following inhalation. Fundam Appl Toxicol. 29(2):269–279.
  • Hext PM. 1994. Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol. 13(10):700–715.
  • Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 9(8):847–856.
  • Hurbankova M, Cerna S, Gergelova P, Wimmerova S. 2005. Influence of refractory ceramic fibres – asbestos substitute - on the selected parameters of bronchoalveolar lavage 6 months after intratracheal instillation to W-rats. Biomed Pap Med. 149(2):367–371.
  • IARC. 1988. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 43: man-made mineral fibres and radon. Chapter 2. Production, use, occurrance and analysis. Lyon, France: World Health Organization (WHO)-International Agency for Research on Cancer (IARC).
  • IARC. 2002. IARC monographs on the evaluation of the carcinogenic risk of humans: man-made vitreous fibers. Vol. 81. Lyon: International Agency for Research on Cancer.
  • ILSI. 2005. Testing of fibrous particles: short-term assays and strategies. Report of an International Life Sciences Institute (ILSI) Risk Science Institute Working Group. Inhal Toxicol. 17:497–537.
  • Innes E, Yiu HHP, McLean P, Brown W, Boyles M. 2021. Simulated biological fluids - a systematic review of their biological relevance and use in relation to inhalation toxicology of particles and fibres. Crit Rev Toxicol. 51(3):217–248.
  • Kamstrup O, Davis JM, Ellehauge A, Guldberg M. 1998. The biopersistence and pathogenicity of man-made vitreous fibres after short- and long-term inhalation. Ann Occup Hyg. 42(3):191–199.
  • Kamstrup O, Ellehauge A, Chevalier J, Davis JM, McConnell EE, Thevenaz P. 2001. Chronic inhalation studies of two types of stone wool fibers in rats. Inhal Toxicol. 13(7):603–621.
  • Kamstrup O, Ellehauge A, Collier CG, Davis JM. 2002. Carcinogenicity studies after intraperitoneal injection of two types of stone wool fibres in rats. Ann Occup Hyg. 46(2):135–142.
  • Kane AB, Hurt RH, Gao H. 2018. The asbestos-carbon nanotube analogy: an update. Toxicol Appl Pharmacol. 361:68–80.
  • Keller J, Wohlleben W, Ma-Hock L, Strauss V, Gröters S, Küttler K, Wiench K, Herden C, Oberdörster G, van Ravenzwaay B, et al. 2014. Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch Toxicol. 88(11):2033–2059.
  • Kovacikova Z, Hurbankova M, Tatrai E, Cerna S. 2005. Effect of intratracheal fibres exposure on the rat lung. Biomed Pap Med. 149(2):363–365.
  • Krombach F, Munzing S, Allmeling AM, Gerlach JT, Behr J, Dorger M. 1997. Cell size of alveolar macrophages: an interspecies comparison. Environ Health Perspect. 105:1261–1263.
  • Le Bouffant L, Daniel H, Henin JP, Martin JC, Normand C, Tichoux G, Trolard F. 1987. Experimental study on long-term effects of inhaled MMMF on the lungs of rats. Ann Occup Hyg. 31(4B):765–790.
  • Lee KP, Barras CE, Griffith FD, Waritz RS, Lapin CA. 1981. Comparative pulmonary responses to inhaled inorganic fibers with asbestos and fiberglass. Environ Res. 24(1):167–191.
  • Lippmann M. 1988. Asbestos exposure indices. Environ Res. 46(1):86–106.
  • Lippmann M. 1990. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 88:311–317.
  • Lippmann M. 1994. Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma. Occup Environ Med. 51(12):793–798.
  • Lum H, Tyler WS, Hyde DM, Plopper CG. 1983. Morphometry of in situ and lavaged pulmonary alveolar macrophages from control and ozone-exposed rats. Exp Lung Res. 5(1):61–77.
  • Madl AK, Pinkerton KE. 2009. Health effects of inhaled engineered and incidental nanoparticles. Crit Rev Toxicol. 39(38):639–658.
  • Madl AK, Sun RM, Silva T, Kadir  , Pinkerton KE. 2018. Particle toxicities. Chapter 15. In: Charlene A. McQueen, editor. Comprehensive Toxicology. 3rd Edition. Oxford: Elsevier. p. 263–301.
  • Martin RA, Poynter ME. 2016. The immunobiology of asthma. Encyclop Immunobiol. 5:295–305.
  • Mast RW, Hesterberg TW, Glass LR, McConnell EE, Anderson R, Bernstein DM. 1994. Chronic inhalation and biopersistence of refractory ceramic fiber in rats and hamsters. Environ Health Perspect. 102(Suppl 5):207–209.
  • Mast RW, McConnell EE, Anderson R, Chevalier J, Kotin P, Bernstein DM, Thevenaz P, Glass LR, Miiller WC, Hesterberg TW. 1995a. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol. 7(4):425–467.
  • Mast RW, McConnell EE, Hesterberg TW, Chevalier J, Kotin P, Thevenaz P, Bernstein DM, Glass LR, Miiller W, Anderson R. 1995b. Multiple-dose chronic inhalation toxicity study of size-separated kaolin refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol. 7(4):469–502.
  • Mast RW, Yu CP, Oberdorster G, McConnell EE, Utell MJ. 2000. A retrospective review of the carcinogenicity of refractory ceramic fiber in two chronic fischer 344 rat inhalation studies: an assessment of the MTD and implications for risk assessment. Inhal Toxicol. 12(12):1141–1172.
  • Maxim LD, Boymel P, Chase GR, Bernstein DM. 2002. Indices of fiber biopersistence and carcinogen classification for synthetic vitreous fibers (SVFs). Regul Toxicol Pharmacol. 35(3):357–378.
  • Maxim LD, Hadley JG, Potter RM, Niebo R. 2006. The role of fiber durability/biopersistence of silica-based synthetic vitreous fibers and their influence on toxicology. Regul Toxicol Pharmacol. 46(1):42–62.
  • Maxim LD, Mast RW, Utell MJ, Yu CP, Boymel PM, Zoitos BK, Cason JE. 1999. Hazard assessment and risk analysis of two new synthetic vitreous fibers. Regul Toxicol Pharmacol. 30(1):54–74.
  • Maxim LD, McConnell EE. 2001. Interspecies comparisons of the toxicity of asbestos and synthetic vitreous fibers: a weight-of-the-evidence approach. Regul Toxicol Pharmacol. 33(3):319–342.
  • McConnell EE. 1994. Synthetic vitreous fibers-inhalation studies. Regul Toxicol Pharmacol. 20(3 Pt 2):S22–S34.
  • McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt J, Oberdorster G, Chase GR, Thevenaz P, Kotin P. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol. 11(9):785–835.
  • Miller BG, Searl A, Davis JM, Donaldson K, Cullen RT, Bolton RE, Buchanan D, Soutar CA. 1999. Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg. 43(3):155–166.
  • Monchaux G, Bignon J, Jaurand MC, Lafuma J, Sebastien P, Masse R, Hirsch A, Goni J. 1981. Mesotheliomas in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibres. Carcinogenesis. 2(3):229–236.
  • Muhle H, Bellmann B. 1997. Significance of the biodurability of man-made vitreous fibers to risk assessment. Environ Health Perspect. 105(Suppl 5):1045–1047.
  • Muhle H, Bellmann B, Pott F. 1994. Comparative investigations of the biodurability of mineral fibers in the rat lung. Environ Health Perspect. 102(Suppl 5):163–168.
  • Muhle H, Creutzenberg O, Bellmann B, Heinrich U, Mermelstein R. 1990. Dust overloading of lungs: investigations of various materials, species differences, and irreversibility of effects. J Aerosol Med. 3:S-111–S–128.
  • Muhle H, Mangelsdorf I. 2003. Inhalation toxicity of mineral particles: critical appraisal of endpoints and study design. Toxicol Lett. 140–141:223–228.
  • Muhle H, Pott F. 2000. Asbestos as reference material for fibre-induced cancer. Int Arch Occup Environ Health. 73:S53–S59.
  • Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U. 1987. Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg. 31(4B):755–764.
  • Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, et al. 2011. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol. 178(6):2587–2600.
  • NEHC. 1997. Man-made vitreous fibers (Technical manual NEHC-TM6290.91-1 Rev). A. Norfolk, VA: Navy Environmental Health Center (NEHC). p. 110.
  • NIOSH. 1980. Workplace exposure to asbestos: review and recommendations. DHHS (NIOSH) Publication No. 81-103. NIOSH-OSHA Asbestos Work Group April 1980. Washington, DC: U.S. Department of Health and Human Resources, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health (NIOSH). p. 1–47.
  • NRC. 2000. Review of the U.S. Navy’s exposure standard for manufactured vitreous fibers. Washington, DC: National Research Council Subcommittee on Manufactured Vitreous, Fibers (NRC). National Academies Press (US).
  • NTP. 2011. Certain glass wool fibers (inhalable). National Toxicology Program (NTP). Rep Carcinog. 12:207–215.
  • Oberdorster G. 2000. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health. 73:S60–S68.
  • OECD. 2018. Assessment of biodurability of nanomaterials and their surface ligands. Series on the safety of manufactured nanomaterials. Paris, France: Environment Directorate, Organisation for Economic Cooperation and Development (OECD) (No. 86, ENV/JM/MONO(2018)11).
  • OECD. 2020a. Ability of biopersistent/biodurable manufactured nanomaterials (MNs to induce lysosomal membrane permeabilization (LMP) as a prediction of their long-term toxic effects, Series on the Safety of Manufactured Nanomaterials. Paris, France: Environment Directorate, Organisation for Economic Cooperation and Development (OECD) (No. 92, ENV/JM/MONO(2020)32).
  • OECD. 2020b. Guidance document for the testing of dissolution and dispersion stability of nanomaterials and the use of the data for further environmental testing and assessment strategies. Series on Testing and Assessment. Paris, France: Environment Directorate, Organisation for Economic Cooperation and Development (OECD) (No. 318, ENV/JM/MONO(2020)9).
  • OEHHA. 2011. Modification of the listing of glasswool fibers (airborne particles of respirable size) to glass wool fibers (inhalable and biopersistent). Sacramento, CA: California Office of Environmental Health Hazard Assessment (OEHHA).
  • Osmond-McLeod MJ, Poland CA, Murphy F, Waddington L, Morris H, Hawkins SC, Clark S, Aitken R, McCall MJ, Donaldson K. 2011. Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol. 8(1):15.
  • Peijnenburg W, Ruggiero E, Boyles M, Murphy F, Stone V, Elam DA, Werle K, Wohlleben W. 2020. A method to assess the relevance of nanomaterial dissolution during reactivity testing. Materials. 13(10):2235.
  • Pigott GH, Ishmael J. 1992. The effects of intrapleural injections of alumina and aluminosilicate (ceramic) fibres. Int J Exp Pathol. 73(2):137–146.
  • Pott F. 1998. Carcinogenicity of fibers in experimental animals data and evaluation. Assessment of Inhalation Hazards. ILSI Monographs, Springer Nature. p. 243–253.
  • Pott F, Friedrichs KH. 1972. Tumors in the rat following intraperitoneal injections of fibrous dust. Naturwissenschaften. 59(7):318.
  • Pott F, Friedrichs KH, Huth F. 1976. Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their interpretation with regard to the carcinogenesis in humans (author’s transl). Zentralbl Bakteriol Orig B. 162(5–6):467–505.
  • Pott F, Matscheck A, Ziem U, Muhle H, Huth F. 1988. Animal experiments with chemically treated fibres. Ann Occup Hyg. 32:353–359.
  • Pott F, Roller M, Althoff GH, Kamino K, Bellmann B, Ulm K. 1993. Estimation of the carcinogenicity of inhaled fibres. VDI Berichte, Kolloquium Faserformige Staube, Conference Paper No. 1075, pp. 17–77 (in German). Dusseldorf: VD-Verlag.
  • Pott F, Roller M, Kamino K, Bellmann B. 1994. Significance of durability of mineral fibers for their toxicity and carcinogenic potency in the abdominal cavity of rats in comparison with the low sensitivity of inhalation studies. Environ Health Perspect. 102(Suppl 5):145–150.
  • Pott F, Ziem U, Reiffer FJ, Huth F, Ernst H, Mohr U. 1987. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp Pathol. 32(3):129–152.
  • Roller M, Pott F, Kamino K, Althoff GH, Bellmann B. 1996. Results of current intraperitoneal carcinogenicity studies with mineral and vitreous fibres. Exp Toxicol Pathol. 48(1):3–12.
  • Roller M, Pott F, Kamino K, Althoff GH, Bellmann B. 1997. Dose-response relationship of fibrous dusts in intraperitoneal studies. Environ Health Perspect. 105(Suppl 5):1253–1256.
  • Sayan M, Mossman BT. 2016. The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 13(1):51.
  • Schlesinger R. 1995. Deposition and clearance of inhaled particles. In McClellan RO, Henderson RF, editors. Concepts in inhalation toxicology. Washington, DC: Taylor and Francis. p. 191–224.
  • Searl A, Buchanan D, Cullen RT, Jones AD, Miller BG, Soutar CA. 1999. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg. 43(3):143–153.
  • Sebastian K, Fellman J, Potter R, Bauer J, Searl A, de Meringo A, de Reydellet A, Jubb G, Moore M, Preininger R. 2002. EURIMA test guideline: in-vitro acellular dissolution of man-made vitreous silicate fibres. Glass Sci Technol. 75(5):263–270.
  • Sebring RJ, Lehnert BE. 1992. Morphometric comparisons of rat alveolar macrophages, pulmonary interstitial macrophages, and blood monocytes. Exp Lung Res. 18(4):479–496.
  • Smith DM, Ortiz LW, Archuleta RF, Johnson NF. 1987. Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann Occup Hyg. 31(4B):731–754.
  • Snipes M. 1995. Pulmonary retention of particles and fibers: biokinetics and effects of exposure concentration. In McClellan OO, Henderson RF, editors. Concepts in inhalation toxicology. Washington, DC: Taylor and Francis. p. 191–224.
  • Stanton MF. 1973. Some etiological considerations of fibre carcinogenesis. In Bogovski P, Timbrell V, Gilson JC, Wagner JC, editors. Biological effects of asbestos: Proceedings of a Working Conference. IARC Scientific Publications No. 8. Lyon: International Agency for Research on Cancer. p. 289–294.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. 1981a. Relation of particle dimension of carcingenicity in amphibole asbestosis and other fibrosis minerals. J Natl Cancer Inst. 67:965–975.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. 1981b. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 67(5):965–975.
  • Stanton MF, Laynard M, Tegeris A, Miller E, May M, Kent E. 1977. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst. 58(3):587–603.
  • Stanton MF, Wrench C. 1972. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 48(3):797–821.
  • Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol. 6(2):235–243.
  • Stone RA, Youk AO, Marsh GM, Buchanich JM, Smith T. 2004. Historical cohort study of U.S. man-made production workers IX: summary of 1992 mortality follow up and analysis of respiratory system cancer among female workers. J Occup Environ Med. 46(1):55–67.
  • Strom KA, Yu CP. 1994. Mathematical modeling of silicon-carbide whisker deposition in the lung-comparison between rats and humans. Aerosol Sci Technol. 24(3):193–209.
  • Sussman R, Cohen B, Lippmann M. 1991a. Asbestos fiber deposition in a human tracheobronchial cast. I. Experimental. Inhal Toxicol. 3(2):145–160.
  • Sussman RG, Cohen BS, Lippmann M. 1991b. Asbestos fiber deposition in a human trancheobronchial cast. II. Empirical Model. Inhal Toxicol. 3(2):161–179.
  • TIMA. 1990. Health and safety aspects of man-made vitreous fibers. Information, data, comments and recommendations regarding occupational exposure to man-made vitreous fibers. Submitted by Thermal Insulation Manufacturers Association (TIMA) in Response to NIOSH request for comments and secondary data relevant to occupational exposure to synthetic and natural mineral fibers. Fed Regist. 55(5073):347.
  • Topinka JB, Loli P, Dusinska M, Hurbankova M, Kovacikova Z, Volkovova K, Kazimirova A, Barancokova M, Tatrai E, Wolff T, et al. 2006. Mutagenesis by man-made mineral fibres in the lung of rats. Mutat Res. 595(1-2):174–183.
  • Utembe W, Potgieter K, Stefaniak AB, Gulumian M. 2015. Dissoluation and biodurability: important parameters needed for risk assessment of nanomaterials. Part Fibre Toxicol. 12(11):11–12.
  • Vorwald AJ, Durkan TM, Pratt PC. 1951. Experimental Studies of Asbestosis. Arch Indust Hyg Occup Med. 3(1):1–43.
  • Wagner JC. 1963. Asbestosis in experimental animals. Br J Ind Med. 20(1):1–12.
  • Wagner JC. 1976. Tumours in experimental animals following exposure to asbestos dust. Ann Anat Pathol. 21(2):211–214.
  • Wagner JC. 1990. Biological effects of short fibers. In Proceedings of the VIIth International Pneumoconiosis Conference Part II, November. DHHS (NIOSH) Publication No. 90-108 Part II. Animal Models- Pneumoconiosis II. November 1990. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health. p. 835–839.
  • Wagner JC, Berry G. 1969. Mesotheliomas in rats following inoculation with asbestos. Br J Cancer. 23(3):567–581.
  • Wagner JC, Berry G, Hill RJ, Munday DE, Skidmore JW. 1980. Animal experiments with man-made mineral fibres. IARC Sci Publ. (30):361–362.
  • Wagner JC, Berry G, Timbrell V. 1973. Mesotheliomata in rats after inoculation with asbestos and other materials. Br J Cancer. 28(2):173–185.
  • Wagner JC, Griffiths DM, Hill RJ. 1984. The effect of fibre size on the in vivo activity of UICC crocidolite. Br J Cancer. 49(4):453–458.
  • Warheit D, Hartsky MA, et al. 1994. Influences of gender, species and strain differences in pulmonary toxicological assessments of inhaled particles and/or fibers. In Mohr U, Dungworth DL, Mauderly JL editors. Toxic and carcinogenic effects of solid particles in the respiratory tract. Washington, DC: ILSI Press.
  • WHO. 2000. Air quality guidelines - second edition. Chapter 8.2: Man-made vitreous fibres. Air quality guidelines for Europe 2nd Edition WHO Regional Publications European Series No 91. Copenhagen, Denmark: World Health Organization (WHO) Regional Office for Europe; p. 18. Retrieved February 15, 2022 from: https://www.euro.who.int/__data/assets/pdf_file/0004/123088/AQG2ndEd_8_2MMVF.pdf.
  • Wylie AG, Virta RL, Segreti JM. 1987. Characterization of mineral population by index particle: IMPLICATION for the Stanton hypothesis. Environ Res. 43(2):427–439.
  • Yu CP, Zhang L, Oberdorster G, Mast RW, Glass LR, Utell MJ. 1994. Deposition of refractory ceramic fibers (RCF) from the rat lung: development of a model. Environ Res. 65(2):243–253.